JPM vs ORMP
JPMorgan Chase & Co (JPM) versus Oramed Pharmaceuticals Inc (ORMP) — a side-by-side from cached financials, not a winner call.
JPMorgan Chase & Co (JPM) is a banks - diversified company listed on US. It is led by Jamie Dimon.
Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.
Latest reported JPM revenue for 2025-12-31 was $182.45B. Net income was $57.05B. Revenue was up 2.8% from 2024-12-31 to 2025-12-31. JPM currently screens at market cap $805.69B and trailing P/E 14.2.
Latest reported ORMP revenue for 2023-12-31 was $1.3M. Net income was $5.5M. Revenue was up 48.2% from 2022-12-31 to 2023-12-31. ORMP currently screens at market cap $87.2M.
JPM currently screens at market cap $805.69B and trailing P/E 14.2. ORMP currently screens at market cap $87.2M.
Not investment advice. Open the JPM and ORMP stock pages for the full models.
Not investment advice.